Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres)
- PMID: 18467306
- DOI: 10.1093/jac/dkn174
Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres)
Abstract
Objectives: The aim of this study was to assess antibiotic resistance rates and mechanisms of beta-lactam and aminoglycoside resistance among isolates of Pseudomonas aeruginosa isolated in the extra-hospital setting (community and private healthcare centres).
Patients and methods: During a 4 month period, 226 non-repetitive strains of P. aeruginosa were collected from patients residing in private healthcare centres (73.5%) or at home (26.5%). Resistance rates were evaluated by MIC determination, and beta-lactam and aminoglycoside resistance was analysed by phenotypic tests, PCR amplification, cloning and sequencing.
Results: Among the ticarcillin-resistant strains (38.1%), 33.7% overexpressed their chromosomal cephalosporinase, 27.9% produced acquired penicillinases (21 PSE-1, 2 OXA-21 and 1 TEM-2), 4.7% produced extended-spectrum beta-lactamases (ESBLs) (3 TEM-21 and 1 SHV-2a) and 45.3% possessed a non-enzymatic resistance (NER). Thus, 88.4% had a single mechanism of resistance, whereas 11.6% cumulated several mechanisms. No carbapenemases were detected among the 6.6% imipenem-resistant strains. With regard to aminoglycosides, 23.0% of the strains exhibited an acquired resistance to gentamicin (GEN), tobramycin (TOB), amikacin (AMK) or netilmicin (NET). Enzymatic resistance was more frequent (71.2%) than NER (34.6%). Various aminoglycoside modifying enzymes were associated with overlapping phenotypes: 36.5% strains produced AAC(6')-I with either a serine (GEN-TOB-NET) or a leucine (TOB-NET-AMK) at position 119, or both variants (GEN-TOB-NET-AMK); 21.2% expressed ANT(2'')-I (GEN-TOB), 7.7% AAC(3)-II (GEN-TOB-NET), 5.8% AAC(3)-I (GEN) and 1.9% AAC(6')-II (GEN-TOB-NET-AMK) or AACA7 (TOB-NET-AMK).
Conclusions: Antibiotic resistance rates in P. aeruginosa were globally similar in general practice as in French hospitals. This first analysis of resistance mechanisms showed an unexpectedly high frequency of ESBLs and an unusual distribution of aminoglycoside modifying enzymes.
Similar articles
-
[Present status of the sensitivity of Pseudomonas aeruginosa to aminoglycosides in France].Pathol Biol (Paris). 1986 Jun;34(5 Pt 2):621-4. Pathol Biol (Paris). 1986. PMID: 3095779 French.
-
Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study.J Antimicrob Chemother. 2008 Sep;62(3):479-83. doi: 10.1093/jac/dkn244. Epub 2008 Jul 7. J Antimicrob Chemother. 2008. PMID: 18606785
-
[Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].Zhonghua Yi Xue Za Zhi. 2008 Jul 8;88(26):1859-62. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19040025 Chinese.
-
Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa.Crit Rev Microbiol. 2010 Aug;36(3):245-58. doi: 10.3109/1040841X.2010.481763. Crit Rev Microbiol. 2010. PMID: 20482453 Review.
-
[Interpretive reading of the non-fermenting gram-negative bacilli antibiogram].Enferm Infecc Microbiol Clin. 2010 Dec;28(10):726-36. doi: 10.1016/j.eimc.2010.05.001. Epub 2010 Jun 26. Enferm Infecc Microbiol Clin. 2010. PMID: 20579775 Review. Spanish.
Cited by
-
Antibiotic susceptibility profiles and first report of TEM extended-spectrum β-lactamase in Pseudomonas fluorescens from coastal waters of the Kaštela Bay, Croatia.World J Microbiol Biotechnol. 2012 May;28(5):2039-45. doi: 10.1007/s11274-012-1006-5. Epub 2012 Feb 2. World J Microbiol Biotechnol. 2012. PMID: 22806025
-
Isolation of VIM-2-producing Pseudomonas monteilii clinical strains disseminated in a tertiary hospital in northern Spain.Antimicrob Agents Chemother. 2015 Feb;59(2):1334-6. doi: 10.1128/AAC.04639-14. Epub 2014 Nov 24. Antimicrob Agents Chemother. 2015. PMID: 25421471 Free PMC article.
-
Spectrum of Aminoglycoside Modifying Enzymes in Gram-Negative Bacteria Causing Human Infections.J Lab Physicians. 2020 Mar;12(1):27-31. doi: 10.1055/s-0040-1713687. Epub 2020 Aug 11. J Lab Physicians. 2020. PMID: 32792790 Free PMC article.
-
Prevalence of class 1, 2 and 3 integrons among multidrug-resistant Pseudomonas aeruginosa in Yazd, Iran.Iran J Microbiol. 2018 Oct;10(5):300-306. Iran J Microbiol. 2018. PMID: 30675326 Free PMC article.
-
Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of Pseudomonas aeruginosa in the North of Iran.Biomed Res Int. 2021 Aug 21;2021:7077344. doi: 10.1155/2021/7077344. eCollection 2021. Biomed Res Int. 2021. PMID: 34471641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical